A phase 2 trial to evaluate the efficacy of recombinant idiotype vaccine with abbreviated course of granulocyte-macrophage colony-stimulating factor adjuvant in follicular non-Hodgkin's lymphoma.

被引：0
|
作者：
Vose, J
Bierman, P
Hollingsworth, M
Ingolia, D
Denney, D
Kunkel, L
机构：
[1] Univ Nebraska, Med Ctr, Omaha, NE USA
[2] Genitope Corp, Redwood City, CA USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1397
引用
收藏
页码：361A / 361A
页数：1
相关论文
共 50 条
  • [1] Immunization with recombinant human granulocyte-macrophage colony-stimulating factor as a vaccine adjuvant elicits both a cellular and humoral response to recombinant human granulocyte-macrophage colony-stimulating factor
    McNeel, DG
    Schiffman, K
    Disis, ML
    BLOOD, 1999, 93 (08) : 2653 - 2659
  • [2] IDIOTYPE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FUSION PROTEIN AS A VACCINE FOR B-CELL LYMPHOMA
    TAO, MH
    LEVY, R
    NATURE, 1993, 362 (6422) : 755 - 758
  • [3] Granulocyte-macrophage colony-stimulating factor interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: Results of a randomized double-blind trial
    Vose, JM
    Pandite, AN
    Beveridge, RA
    Geller, RB
    Schuster, MW
    Anderson, JE
    LeMaistre, CF
    Ahmed, T
    Granena, A
    Keating, A
    Ranada, JMF
    Stiff, PJ
    Tabbara, I
    Longo, W
    Copelan, EA
    Nichols, C
    Smith, A
    Topolsky, DL
    Bierman, PJ
    Lebsack, ME
    Lange, M
    Garrison, L
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1617 - 1623
  • [4] Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphoma - A randomised pilot study
    Bergmann, L
    Karakas, T
    Knuth, A
    Lautenschlager, G
    Mitrou, PS
    Hoelzer, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2164 - 2168
  • [5] A PHASE-II STUDY OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH NON-HODGKINS-LYMPHOMA
    MUGHAL, TI
    ONEILL, K
    LEUKEMIA & LYMPHOMA, 1994, 14 (3-4) : 331 - 334
  • [6] PHASE-I TRIAL OF THIOTEPA IN COMBINATION WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    ODWYER, PJ
    LACRETA, FP
    SCHILDER, R
    NASH, S
    MCALEER, C
    MILLER, LL
    HUDES, GR
    OZOLS, RF
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (08) : 1352 - 1358
  • [7] Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin’s lymphoma
    Joseph A. Sparano
    Abdissa Negassa
    Erick Lansigan
    Robin Locke
    Chamath R. De Silva
    Peter H. Wiernik
    Medical Oncology, 2005, 22 : 257 - 267
  • [8] Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-Hodgkin's lymphoma
    Sparano, JA
    Negassa, A
    Lansigan, E
    Locke, R
    De Silva, CR
    Wiernik, PH
    MEDICAL ONCOLOGY, 2005, 22 (03) : 257 - 267
  • [9] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH ADVANCED MALIGNANCY - A PHASE-IB TRIAL
    STEIS, RG
    VANDERMOLEN, LA
    LONGO, DL
    CLARK, JW
    SMITH, JW
    KOPP, WC
    RUSCETTI, FW
    CREEKMORE, SP
    ELWOOD, LJ
    HURSEY, J
    URBA, WJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (08) : 697 - 703
  • [10] Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma:: Results of a phase II study
    Cartron, Guillaume
    Zhao-Yang, Lu
    Baudard, Marion
    Kanouni, Tarik
    Rouille, Valerie
    Quittet, Philippe
    Klein, Bernard
    Rossi, Jean-Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2725 - 2731
12345